Menno M. Schoonheim

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 214 publications

The value of brain age as a transdiagnostic biomarker of neurodegeneration.

The value of brain age as a transdiagnostic biomarker of neurodegeneration.

Journal: medRxiv : the preprint server for health sciences
Published: August 01, 2026

Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

Journal: Neurology
Published: June 18, 2026

Mediation Analysis Between Brain Age, Disease-Modifying Factors, and Disability and Cognitive Performance in Multiple Sclerosis.

Mediation Analysis Between Brain Age, Disease-Modifying Factors, and Disability and Cognitive Performance in Multiple Sclerosis.

Journal: Neurology
Published: June 17, 2026

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Journal: Nature reviews. Neurology
Published: April 13, 2026

What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.

What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.

Journal: Journal of neurology
Published: April 10, 2026

Novel MRI metrics: Is targeting brain atrophy a practical treatment goal? No.

Novel MRI metrics: Is targeting brain atrophy a practical treatment goal? No.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 29, 2026

Sex-dependent bioactive lipid mediator profiles in multiple sclerosis.

Sex-dependent bioactive lipid mediator profiles in multiple sclerosis.

Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: March 18, 2026

The Role of Wearable Devices to Identify Patients at High Risk of Disease Progression in Multiple Sclerosis.

The Role of Wearable Devices to Identify Patients at High Risk of Disease Progression in Multiple Sclerosis.

Journal: Neurology
Published: March 04, 2026

Clinical and MRI substrates of Symbol Digit Modalities Test impairment in multiple sclerosis patients with an adult- and late-onset.

Clinical and MRI substrates of Symbol Digit Modalities Test impairment in multiple sclerosis patients with an adult- and late-onset.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 23, 2026

The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosis.

The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosis.

Journal: Journal of neurology
Published: February 19, 2026

Brain atrophy in multiple sclerosis: Mechanisms, measurement, and clinical translation.

Brain atrophy in multiple sclerosis: Mechanisms, measurement, and clinical translation.

Journal: Revue neurologique
Published: February 01, 2026

Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease Severity.

Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease Severity.

Journal: Neurology
Published: January 30, 2026
Showing 1-12 of 214

Last Updated: 09/26/2026